Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126703491 | 12670349 | 1 | I | 20160809 | 20160822 | 20160822 | EXP | US-GLAXOSMITHKLINE-US2016GSK120368 | GLAXOSMITHKLINE | LAZENBY GB, MMEJE O, FISHER BM, WEINBERG A, AARON EK, KEATING M ET AL. ANTIRETROVIRAL RESISTANCE AND PREGNANCY CHARACTERISTICS OF WOMEN WITH PERINATAL AND NONPERINATAL HIV INFECTION. INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY. 2016;2016:1-8 | 0.00 | F | Y | 0.00000 | 20160822 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126703491 | 12670349 | 1 | PS | Abacavir sulfate + lamivudine | ABACAVIR SULFATELAMIVUDINE | 1 | U | 21652 | |||||||||||
| 126703491 | 12670349 | 2 | SS | Efavirenz | EFAVIRENZ | 1 | U | 0 | |||||||||||
| 126703491 | 12670349 | 3 | SS | RITONAVIR. | RITONAVIR | 1 | U | 0 | |||||||||||
| 126703491 | 12670349 | 4 | SS | DARUNAVIR | DARUNAVIR | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126703491 | 12670349 | 1 | Antiretroviral therapy |
| 126703491 | 12670349 | 2 | Antiretroviral therapy |
| 126703491 | 12670349 | 3 | Antiretroviral therapy |
| 126703491 | 12670349 | 4 | Antiretroviral therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126703491 | 12670349 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126703491 | 12670349 | Drug resistance | |
| 126703491 | 12670349 | Exposure during pregnancy | |
| 126703491 | 12670349 | Pathogen resistance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |